Autologous stem cell transplantation in patients who object to a blood transfusion: contribution of new pharmacological haematopoiesis support. (abre nova janela)

Al-Nawakil C, Quarre MC, Heshmati F, Deau B, Park S, Dreyfus F, Bouscary D, Tamburini J.

Fonte‎: Br J Haematol 2013;161(5):738-40.

Indexado‎: PubMed 23480574

DOI‎: 10.1111/bjh.12284

https://www.ncbi.nlm.nih.gov/pubmed/23480574 (abre nova janela)

Autologous stem-cell transplantation can be performed safely without the use of blood-product support. (abre nova janela)

Ballen KK, Becker PS, Yeap BY, Matthews B, Henry DH, Ford PA.

Fonte‎: J Clin Oncol 2004;22(20):4087-94.

Indexado‎: PubMed 15353543

DOI‎: 10.1200/JCO.2004.01.144

https://www.ncbi.nlm.nih.gov/pubmed/15353543 (abre nova janela)

Safety of bloodless autologous stem cell transplantation in Jehovah's Witness patients. (abre nova janela)

Beck A, Lin R, Reza Rejali A, Rubens M, Paquette R, Vescio R, Merin N, Guerrero M, Federizo Y, Lua M, Uy L, Hernandez L, Allred M, Legaspi R, Leaverton M, Oliva S, Castillo R, Dean L, Bourke J, Cooper S, Gharapetian S, Causin J, Lopiccolo C, Ann Snoussi L, VanStrien P, Lill M, Linhares YP

Fonte‎: Bone Marrow Transplant 2020;55(6):1059-67.

Indexado‎: PubMed 31898692

DOI‎: 10.1038/s41409-019-0777-9

https://www.ncbi.nlm.nih.gov/pubmed/31898692 (abre nova janela)

The use of blood conservation methods in addition to erythropoietin allows myeloablative allogeneic stem cell transplantation without the use of blood products. (abre nova janela)

Ciurea S, Beri R, Dobogai L, Chunduri S, Mahmud N, Rondelli D, Peace D.

Fonte‎: Bone Marrow Transplant 2006;37(3):325-7.

Indexado‎: PubMed 16314850

DOI‎: 10.1038/sj.bmt.1705223

https://www.ncbi.nlm.nih.gov/pubmed/16314850 (abre nova janela)

Hematopoietic stem cell transplantation without the use of blood components by the patient's choice: experience of 2 Brazilian centers. (abre nova janela)

da Silva RL, da Silva LAM, Geraldo BLDSS, Simões AA, Almeida MSS, Fernandes PA, Simões CM, Russo FT, Okada LY, Cavalcante JN, Lopes MAVF, Macedo RA, Macedo MCMA

Fonte‎: Biol Blood Marrow Transplant 2020;26(3):458-62.

Indexado‎: PubMed 31669397

DOI‎: 10.1016/j.bbmt.2019.10.018

https://www.ncbi.nlm.nih.gov/pubmed/31669397 (abre nova janela)

Transfusion challenges in hematology oncology and hematopoietic stem cell transplant - literature review and local experience. (abre nova janela)

Elemary M, Seghatchian J, Stakiw J, Bosch M, Sabry W, Goubran H

Fonte‎: Transfus Apher Sci 2017;56(3):317-21.

Indexado‎: PubMed 28642120

DOI‎: 10.1016/j.transci.2017.05.022

https://www.ncbi.nlm.nih.gov/pubmed/28642120 (abre nova janela)

Autologous stem-cell transplantation without hematopoietic support for the treatment of hematologic malignancies in Jehovah's Witnesses. (abre nova janela)

Ford PA, Grant SJ, Mick R, Keck G.

Fonte‎: J Clin Oncol 2015;33(15):1674-9.

Indexado‎: PubMed 25870085

DOI‎: 10.1200/JCO.2014.57.9912

https://www.ncbi.nlm.nih.gov/pubmed/25870085 (abre nova janela)

Myeloablative chemotherapy and autologous stem cell transplantation without the use of blood products. (abre nova janela)

Jamal F, Lim SW, Vescio R, Pepkowitz S, Van Strien P, Hoshal K, Lill MC.

Fonte‎: Biol Blood Marrow Transplant 2005;11(2 Suppl 1):66-7.

DOI‎: 10.1016/j.bbmt.2004.12.199

http://www.bbmt.org/article/S1083-8791(04)00851-1/fulltext (abre nova janela)

Safety and survival outcomes for bloodless transplantation in patients with myeloma. (abre nova janela)

Joseph NS, Kaufman JL, Boise LH, Valla K, Almaula DK, Obidike CO, Langston AA, Waller EK, Khoury HJ, Flowers CR, Graiser M, Heffner LT, Lonial S, Nooka AK

Fonte‎: Cancer 2019;125(2):185-93.

Indexado‎: PubMed 30480777

DOI‎: 10.1002/cncr.31677

https://www.ncbi.nlm.nih.gov/pubmed/30480777 (abre nova janela)

Bloodless tandem autologous transplant in Jehovah's Witness patients. (abre nova janela)

Khan R, Mott SL, Schultz A, Jethava YS, Tricot G

Fonte‎: Bone Marrow Transplant 2018. [Epub ahead of print]

Indexado‎: PubMed 29795417

DOI‎: 10.1038/s41409-018-0132-6

https://www.ncbi.nlm.nih.gov/pubmed/29795417 (abre nova janela)

Myeloablative therapy and bone marrow transplantation in Jehovah's Witnesses with malignancies: single center experience. (abre nova janela)

Mazza P, Prudenzano A, Amurri B, Palazzo G, Pisapia G, Stani L, Pricolo G.

Fonte‎: Bone Marrow Transplant 2003;32(4):433-6.

Indexado‎: PubMed 12900781

DOI‎: 10.1038/sj.bmt.1704179

https://www.ncbi.nlm.nih.gov/pubmed/12900781 (abre nova janela)

Bloodless (transfusion-free) hematopoietic stem cell transplants: the Mexican experience. (abre nova janela)

Ruiz-Argüelles GJ, Morales-Toquero A, López-Martínez B, Tarín-Arzaga LD, Manzano C.

Fonte‎: Bone Marrow Transplant 2005;36(8):715-20.

Indexado‎: PubMed 16113672

DOI‎: 10.1038/sj.bmt.1705126

https://www.ncbi.nlm.nih.gov/pubmed/16113672 (abre nova janela)

SCT in Jehovah's Witnesses: the bloodless transplant. (abre nova janela)

Sloan JM, Ballen K.

Fonte‎: Bone Marrow Transplant 2008;41(10):837-44.

Indexado‎: PubMed 18246110

DOI‎: 10.1038/bmt.2008.5

https://www.ncbi.nlm.nih.gov/pubmed/18246110 (abre nova janela)